Cover Image

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors

Novel therapies are urgently needed to improve global treatment of SARS-CoV-2 infection. Herein, we briefly provide a concise report on the medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors with representative examples in different strategies from the medicina...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shenghua Gao (Author), Tianguang Huang (Author), Letian Song (Author), Shujing Xu (Author), Yusen Cheng (Author), Srinivasulu Cherukupalli (Author), Dongwei Kang (Author), Tong Zhao (Author), Lin Sun (Author), Jian Zhang (Author), Peng Zhan (Author), Xinyong Liu (Author)
Format:	Book
Published:	Elsevier, 2022-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors
by: Letian Song, et al.
Published: (2024)

Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins
by: Lingxin Hou, et al.
Published: (2022)

Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
by: Shenghua Gao, et al.
Published: (2023)

Recent developments in the medicinal chemistry of single boron atom-containing compounds
by: Shu Song, et al.
Published: (2021)

SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis
by: Shujing Xu, et al.
Published: (2022)

High-throughput modular click chemistry synthesis of catechol derivatives as covalent inhibitors of SARS-CoV-2 3CLpro
by: Feng Wang, et al.
Published: (2024)

Bibliometric analysis and visualization of research trends on HIV-1 capsid inhibitors (2000-2022)
by: Lin Sun, et al.
Published: (2023)

Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants
by: Zhao Wang, et al.
Published: (2024)

Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region
by: Tao Zhang, et al.
Published: (2022)

Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice
by: Mianling Yang, et al.
Published: (2024)

Drupacine as a potent SARS-CoV-2 replication inhibitor in vitro
by: Chen Yang, et al.
Published: (2024)

Discovery of GluN2A subtype-selective N-methyl-d-aspartate (NMDA) receptor ligands
by: Liyang Jiang, et al.
Published: (2024)

The Chemistry of Biofilms and Their Inhibitors
Published: (2020)

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
by: Jingyue Ju, et al.
Published: (2020)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
by: Jiawei Liu, et al.
Published: (2022)

Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics
by: Chris Chun-Yiu Chan, et al.
Published: (2024)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021)

Recent advances in developing small-molecule inhibitors against SARS-CoV-2
by: Rong Xiang, et al.
Published: (2022)

Screening for inhibitors against SARS-CoV-2 and its variants
by: Weijing Yuan, et al.
Published: (2022)

In silico phytochemicals analysis as inhibitors of the SARS-COV-2 main protease
by: Ekaterina Serikova, et al.
Published: (2022)

Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
by: Nirmitee Mulgaonkar, et al.
Published: (2023)

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
by: Katarzyna Papaj, et al.
Published: (2021)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
by: Fucheng Song, et al.
Published: (2023)

The chemistry and efficacy benefits of polysaccharides from Atractylodes macrocephala Koidz
by: Congying Liu, et al.
Published: (2022)

Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality
by: Yang Zhou, et al.
Published: (2023)

Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
by: Wei-Chung Chiou, et al.
Published: (2021)

Prospects for a MERS-CoV spike vaccine
by: Yusen Zhou, et al.
Published: (2018)

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
by: Shufen Li, et al.
Published: (2021)

Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets
by: Zhouman He, et al.
Published: (2023)

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
by: Soumya Gulab Katre, et al.
Published: (2022)

Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies
by: Alberto Jorge Oliveira Lopes, et al.
Published: (2022)

Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
by: Gwenolé Loas, et al.
Published: (2021)

Maternal SARS‐CoV‐2 infection: The potential vertical transmission of SARS‐CoV‐2 and impact on neonates: A review
by: Wei Xia, et al.
Published: (2023)

A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization
by: Letian Li, et al.
Published: (2023)

Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2
by: Renhui Dai, et al.
Published: (2023)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in an outbreak of SARS-CoV-2
by: Didar Yanardag Acik
Published: (2020)

Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein
by: Yu-meng Chen, et al.
Published: (2022)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
by: Arpan Acharya, et al.
Published: (2022)